Cellectis Future Growth
Future criteria checks 2/6
Cellectis is forecast to grow earnings and revenue by 25.9% and 29.2% per annum respectively.
Key information
25.9%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 37.0% |
| Revenue growth rate | 29.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 07 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 116 | -47 | -77 | N/A | 3 |
| 12/31/2025 | 67 | -48 | -96 | N/A | 6 |
| 12/31/2024 | 44 | -57 | 8 | N/A | 5 |
| 9/30/2024 | 36 | -84 | 60 | 63 | N/A |
| 6/30/2024 | 20 | -79 | 51 | 51 | N/A |
| 3/31/2024 | 12 | -78 | -21 | -20 | N/A |
| 12/31/2023 | 9 | -109 | -26 | -25 | N/A |
| 9/30/2023 | 25 | -92 | -67 | -66 | N/A |
| 6/30/2023 | 25 | -97 | -78 | -75 | N/A |
| 3/31/2023 | 25 | -91 | -81 | -79 | N/A |
| 12/31/2022 | 26 | -91 | -90 | -87 | N/A |
| 9/30/2022 | -5 | -63 | -109 | -107 | N/A |
| 6/30/2022 | 4 | -78 | -118 | -112 | N/A |
| 3/31/2022 | 14 | -99 | -111 | -100 | N/A |
| 12/31/2021 | 39 | -86 | -123 | -105 | N/A |
| 9/30/2021 | 68 | -129 | -154 | -117 | N/A |
| 6/30/2021 | 67 | -121 | -151 | -113 | N/A |
| 3/31/2021 | 59 | -113 | -169 | -123 | N/A |
| 12/31/2020 | 60 | -37 | -125 | -80 | N/A |
| 9/30/2020 | 73 | -79 | -80 | -49 | N/A |
| 6/30/2020 | 73 | -66 | -76 | -46 | N/A |
| 3/31/2020 | 71 | -67 | -64 | -45 | N/A |
| 12/31/2019 | 23 | -102 | -82 | -69 | N/A |
| 9/30/2019 | 20 | -88 | -100 | -87 | N/A |
| 6/30/2019 | 11 | -95 | -88 | -79 | N/A |
| 3/31/2019 | 17 | -69 | -77 | -71 | N/A |
| 12/31/2018 | 21 | -79 | -73 | -68 | N/A |
| 9/30/2018 | 25 | -83 | -60 | -57 | N/A |
| 6/30/2018 | 31 | -86 | N/A | -58 | N/A |
| 3/31/2018 | 31 | -105 | N/A | -56 | N/A |
| 12/31/2017 | 34 | -99 | N/A | -52 | N/A |
| 9/30/2017 | 40 | -86 | N/A | -41 | N/A |
| 6/30/2017 | 45 | -74 | N/A | N/A | N/A |
| 3/31/2017 | 57 | -56 | N/A | -28 | N/A |
| 12/31/2016 | 56 | -67 | N/A | -33 | N/A |
| 9/30/2016 | 76 | -45 | N/A | -6 | N/A |
| 6/30/2016 | 74 | -45 | N/A | N/A | N/A |
| 3/31/2016 | 65 | -64 | N/A | -17 | N/A |
| 12/31/2015 | 63 | -23 | N/A | 4 | N/A |
| 9/30/2015 | 39 | -28 | N/A | 2 | N/A |
| 6/30/2015 | 37 | -10 | N/A | 34 | N/A |
| 3/31/2015 | 33 | 12 | N/A | 47 | N/A |
| 12/31/2014 | 32 | 3 | N/A | 51 | N/A |
| 9/30/2014 | 28 | -8 | N/A | 18 | N/A |
| 6/30/2014 | 24 | -21 | N/A | -18 | N/A |
| 3/31/2014 | 21 | -29 | N/A | -22 | N/A |
| 12/31/2013 | 18 | -36 | N/A | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0WA2 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0WA2 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0WA2 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0WA2's revenue (29.2% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0WA2's revenue (29.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0WA2's Return on Equity is forecast to be high in 3 years time